Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

CSC is linked to mineralocorticoid receptor damage, stress, and steroid use, with treatments including drugs and laser therapies to prevent eye damage.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Blocking SEPT4 might help heal wounds and regrow hair faster.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Good nutrition and vitamins are important for healthy skin and can prevent diseases.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Low phosphorus makes Arabidopsis thaliana grow longer root hairs.

BMP signaling prevents hair growth by stopping stem cell activation.

Lowering testosterone speeds up wound healing in male mice.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Wnt, Eda, and Shh pathways are crucial for different stages of sweat gland development in mice.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

A natural steroid in the body may protect against eye damage in glaucoma.

Spironolactone successfully treated hair loss in a 9-year-old girl.

TRPV4 slows hair growth by affecting hair follicle cells.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

Androgens improve memory in adolescent male rats by acting on brain receptors.

Sodium valproate helps skin healing by affecting GABA and histone deacetylase.

Mitochondrial problems in diabetic nerve damage might cause pain by lowering the production of certain nerve-related steroids.

Setipiprant did not significantly improve hair growth in men with hair loss.